title: Rituximab therapy for ankylosing spondylitis associated to demyelinating disease of the central nervous system.
authors.affiliation: Department of Rheumatology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: sergio.heredia@bellvitgehospital.cat.
authors.forename: Sergi
authors.initials: S
authors.lastname: Heredia
authors.affiliation: Department of Rheumatology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: maparicioe@bellvitgehospital.cat.
authors.forename: Maria
authors.initials: M
authors.lastname: Aparicio
authors.affiliation: Department of Rheumatology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: earmengolp@bellvitgehospital.cat.
authors.forename: Eulàlia
authors.initials: E
authors.lastname: Armengol
authors.affiliation: Department of Rheumatology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain. Electronic address: x.juanola@bellvitgehospital.cat.
authors.forename: Xavier
authors.initials: X
authors.lastname: Juanola
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D003711:Demyelinating Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab / Q000009:adverse effects* / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D000069283:Rituximab
keywords: Ankylosing spondylitis; Multiple sclerosis; Rituximab